George Koulaouzidis is a Cardiologist subspecialised in cardiac imaging (transthoracic echocardiogram, stress echo, transoesophageal echo, cardiac CT, cardiac MRI), heart failure, cardio-oncology and cardiomyopathies. His research during his Ph.D. studies (Umea University, Sweden) was focused on the
investigation of the relationship of the coronary artery calcification process with atherosclerotic cardiovascular disease. During his post as a Clinical Lecturer at Hull University he was the lead clinician for the Heart Failure Telehealth service. As part of his research, he led a project that aimed to improve the prediction of clinical deterioration onset in heart failure patients by analyzing daily telemonitory data. As a Clinical Research Physician in Southampton, he was the Principal Investigator of the CHIRON study, a European two-center study that focused on the development of new ambulatory monitoring devices for use in patients with heart failure. During his post as Clinical Research Physician at the European Scanning Center, he led the institute's research activities. He was a leading member of the clinical team that introduced cardiac CT perfusion studies in the UK. In the past, he has been a sub-investigator in the ASCOT, SPARCL and ILLUMINATE multi-center trials at the Cardiovascular Risk Institute of Queen
Elizabeth Hospital.
George Koulaouzidis is a Cardiologist subspecialised in cardiac imaging (transthoracic echocardiogram, stress echo, transoesophageal echo, cardiac CT, cardiac MRI), heart failure, cardio-oncology and cardiomyopathies. His research during his Ph.D. studies (Umea University, Sweden) was focused on the
investigation of the relationship of the coronary artery calcification process with atherosclerotic cardiovascular disease. During his post as a Clinical Lecturer at Hull University he was the lead clinician for the Heart Failure Telehealth service. As part of his research, he led a project that aimed to improve the prediction of clinical deterioration onset in heart failure patients by analyzing daily telemonitory data. As a Clinical Research Physician in Southampton, he was the Principal Investigator of the CHIRON study, a European two-center study that focused on the development of new ambulatory monitoring devices for use in patients with heart failure. During his post as Clinical Research Physician at the European Scanning Center, he led the institute's research activities. He was a leading member of the clinical team that introduced cardiac CT perfusion studies in the UK. In the past, he has been a sub-investigator in the ASCOT, SPARCL and ILLUMINATE multi-center trials at the Cardiovascular Risk Institute of Queen
Elizabeth Hospital.